Clinical Cancer Research
Journal Abbreviation:  CLIN CANCER RES 
ISSN: 1078-0432
    
eISSN: 1557-3265
Publisher: American Association for Cancer Research
  
Publications (68)
  
    
        
    
        
    
    
    
        
            
                
  
  Low cancer stem cell marker expression and low hypoxia identify good prognosis subgroups in HPV(-) HNSCC after postoperative radiochemotherapy: A multicenter study of the DKTK-ROG (2016)
  Linge A, Loeck S, Gudziol V, Nowak A, Lohaus F, Von Neubeck C, Juetz M, et al.
  Journal article
            
                
  
  Clinical trial of oral nelfinavir before and during radiation therapy for advanced rectal cancer (2016)
  Hill EJ, Roberts C, Franklin JM, Enescu M, West N, Macgregor TP, Chu KY, et al.
  Journal article
            
                
  
  Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab (2016)
  Weide B, Martens A, Hassel JC, Berking C, Postow MA, Bisschop K, Simeone E, et al.
  Journal article
            
                
  
  Tumor-Infiltrating Lymphocytes: A Predictive and Prognostic Biomarker in Neoadjuvant-Treated HER2-Positive Breast Cancer (2016)
  Heppner BI, Untch M, Denkert C, Pfitzner BM, Lederer B, Schmitt W, Eidtmann H, et al.
  Journal article
            
                
  
  Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer (2016)
  Janni WJ, Rack B, Terstappen LWMM, Pierga JY, Taran FA, Fehm T, Hall C, et al.
  Journal article
            
                
  
  Genomic EWSR1 Fusion Sequence as Highly Sensitive and Dynamic Plasma Tumor Marker in Ewing Sarcoma (2016)
  Krumbholz M, Hellberg J, Steif B, Bäuerle T, Gillmann C, Fritscher T, Agaimy A, et al.
  Journal article
            
                
  
  Integrated Analysis of PTEN and p4EBP1 Protein Expression as Predictors for pCR in HER2-Positive Breast Cancer (2016)
  Loibl S, Darb-Esfahani S, Huober J, Klimowicz A, Furlanetto J, Lederer B, Hartmann A, et al.
  Journal article
            
                
  
  MGMT promoter methylation is a strong prognostic biomarker for benefit from dose-intensified temozolomide rechallenge in progressive Glioblastoma: The DIRECTOR Trial (2015)
  Weller M, Tabatabai G, Kästner B, Felsberg J, Steinbach JP, Wick A, Schnell O, et al.
  Journal article
            
                
  
  Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium (2015)
  Johnatty SE, Tyrer JP, Kar S, Beesley J, Lu Y, Gao B, Fasching P, et al.
  Journal article
            
                
  
  CD47 Enhances In Vivo Functionality of Artificial Antigen-Presenting Cells (2015)
  Bruns H, Bessell C, Varela JC, Haupt C, Fang J, Pasemann S, Mackensen A, et al.
  Journal article